CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published ahead of print on April 11, 2007
Clin J Am Soc Nephrol 2: 529-542, 2007
© 2007 American Society of Nephrology
doi: 10.2215/CJN.04121206
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.04121206v1
2/3/529    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barisoni, L.
Right arrow Articles by Kopp, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barisoni, L.
Right arrow Articles by Kopp, J. B.

In-Depth Reviews

A Proposed Taxonomy for the Podocytopathies: A Reassessment of the Primary Nephrotic Diseases

Laura Barisoni*, H. William Schnaper{dagger}, and Jeffrey B. Kopp{ddagger}

* Department of Pathology, New York University School of Medicine, New York, New York; {dagger} Division of Kidney Diseases, Department of Pediatrics, Feinberg School of Medicine, Northwestern University School of Medicine, Chicago, Illinois; and {ddagger} Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland

Address correspondence to: Dr. H. William Schnaper, 303 E. Chicago Avenue, Chicago, IL 60611-3008. Phone: 312-503-1180; Fax: 312-503-1181; E-mail: schnaper{at}northwestern.edu

A spectrum of proteinuric glomerular diseases results from podocyte abnormalities. The understanding of these podocytopathies has greatly expanded in recent years, particularly with the discovery of more than a dozen genetic mutations that are associated with loss of podocyte functional integrity. It is apparent that classification of the podocytopathies on the basis of morphology alone is inadequate to capture fully the complexity of these disorders. Herein is proposed a taxonomy for the podocytopathies that classifies along two dimensions: Histopathology, including podocyte phenotype and glomerular morphology (minimal-change nephropathy, focal segmental glomerulosclerosis, diffuse mesangial sclerosis, and collapsing glomerulopathy), and etiology (idiopathic, genetic, and reactive forms). A more complete understanding of the similarities and differences among podocyte diseases will help the renal pathologist and the nephrologist communicate more effectively about the diagnosis; this in turn will help the nephrologist provide more accurate prognostic information and select the optimal therapy for these often problematic diseases. It is proposed that final diagnosis of the podocytopathies should result from close collaboration between renal pathologists and nephrologists and should whenever possible include three elements: Morphologic entity, etiologic form, and specific pathogenic mechanism or association.




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
R John and A M Herzenberg
Renal toxicity of therapeutic drugs
J. Clin. Pathol., June 1, 2009; 62(6): 505 - 515.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. M. Henderson, M. P. Alexander, and M. R. Pollak
Patients with ACTN4 Mutations Demonstrate Distinctive Features of Glomerular Injury
J. Am. Soc. Nephrol., May 1, 2009; 20(5): 961 - 968.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Suzuki, T. Matsusaka, M. Nakayama, T. Asano, T. Watanabe, I. Ichikawa, and M. Nagata
Genetic Podocyte Lineage Reveals Progressive Podocytopenia with Parietal Cell Hyperplasia in a Murine Model of Cellular/Collapsing Focal Segmental Glomerulosclerosis
Am. J. Pathol., May 1, 2009; 174(5): 1675 - 1682.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Vizjak, D. Ferluga, M. Rozic, A. Hvala, J. Lindic, T. K. Levart, V. Jurcic, and J. C. Jennette
Pathology, Clinical Presentations, and Outcomes of C1q Nephropathy
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2237 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Albaqumi and L. Barisoni
Current Views on Collapsing Glomerulopathy
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1276 - 1281.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. M. Waters, M. Y.J. Wu, T. Onay, J. Scutaru, J. Liu, C. G. Lobe, S. E. Quaggin, and T. D. Piscione
Ectopic Notch Activation in Developing Podocytes Causes Glomerulosclerosis
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1139 - 1157.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Barisoni
Notch Signaling: A Common Pathway of Injury in Podocytopathies?
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1045 - 1046.
[Full Text] [PDF]

Home page
 CJASNHome page
M. R. Pollak, M. P. Alexander, and J. M. Henderson
A Case of Familial Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1367 - 1374.
[Full Text] [PDF]

Home page
 CJASNHome page
M. E. Cho, D. C. Smith, M. H. Branton, S. R. Penzak, and J. B. Kopp
Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 906 - 913.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society of Nephrology.